Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases
International Journal of Molecular Sciences · 18.06.2024 · 25 (12) · 6682
DOI: 10.3390/ijms25126682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2024. Verfasst von Kijan Crowley und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology and Toxicology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGG…. Hauptthemen laut MEDLINE: Cannabinoids, Gastrointestinal Motility, Gastrointestinal Diseases, Permeability. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science development fund of the Warsaw University of Life Sciences—SGGW.
Abstract (Originalsprache)
Cannabinoids and their receptors play a significant role in the regulation of gastrointestinal (GIT) peristalsis and intestinal barrier permeability. This review critically evaluates current knowledge about the mechanisms of action and biological effects of endocannabinoids and phytocannabinoids on GIT functions and the potential therapeutic applications of these compounds. The results of ex vivo and in vivo preclinical data indicate that cannabinoids can both inhibit and stimulate gut peristalsis, depending on various factors. Endocannabinoids affect peristalsis in a cannabinoid (CB) receptor-specific manner; however, there is also an important interaction between them and the transient receptor potential cation channel subfamily V member 1 (TRPV1) system. Phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) impact gut motility mainly through the CB1 receptor. They were also found to improve intestinal barrier integrity, mainly through CB1 receptor stimulation but also via protein kinase A (PKA), mitogen-associated protein kinase (MAPK), and adenylyl cyclase signaling pathways, as well as by influencing the expression of tight junction (TJ) proteins. The anti-inflammatory effects of cannabinoids in GIT disorders are postulated to occur by the lowering of inflammatory factors such as myeloperoxidase (MPO) activity and regulation of cytokine levels. In conclusion, there is a prospect of utilizing cannabinoids as components of therapy for GIT disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pharmacology and Toxicology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland.
- Department of Research and Processing Seed, Institute of Natural Fibers and Medicinal Plants-National Research Institute, Wojska Polskiego 71b, 60-630 Poznan, Poland.
ORCID-Profile: Kijan Crowley, Edyta Miszczuk, Joanna Banach, Urszula Latek, Marta Mendel
Förderung
- Science development fund of the Warsaw University of Life Sciences—SGGW
Zitieren
APA
Crowley, K., Kiraga, Ł., Miszczuk, E., Skiba, S., Banach, J., Latek, U., Mendel, M., & Chłopecka, M. (2024). Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases. International Journal of Molecular Sciences, 25(12), 6682. https://doi.org/10.3390/ijms25126682
Vancouver
Crowley K, Kiraga Ł, Miszczuk E, Skiba S, Banach J, Latek U, et al. Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases. International Journal of Molecular Sciences. 2024;25(12):6682. doi:10.3390/ijms25126682
BibTeX
@article{Crowley2024,
author = {Crowley, Kijan and Kiraga, Łukasz and Miszczuk, Edyta and Skiba, Sergiusz and Banach, Joanna and Latek, Urszula and Mendel, Marta and Chłopecka, Magdalena},
title = {Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {12},
pages = {6682},
doi = {10.3390/ijms25126682}
}
EUVIMED